Tuesday, December 30, 2025
Today's Print

Tag: Phase 3 trials

Sinopharm avers 75% potent, touts as Asian success

Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs...

Pfizer says COVID-19 vaccine 90% effective in Phase 3 trial

A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing COVID-19 infections in ongoing Phase 3 trials, the companies announced...
- Advertisement -spot_img
- Advertisement -spot_img